Can provision of ambulatory nutrition services to patients discharged from acute care improve health outcomes at an acceptable cost?
- Conditions
- Malnutrition in Hospitalized patientsDiet and Nutrition - Other diet and nutrition disordersPublic Health - Health service research
- Registration Number
- ACTRN12614000833662
- Lead Sponsor
- Dr Yogesh Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 112
Patients admitted to general medicine ward aged sixty years or above, Ability to provide written consent or consent obtained from legal guardian if cognitively impaired, Identified as malnourished according to a standard malnutrition screening instrument-Malnutrition Universal Screening Tool (MUST).
Resides outside metropolitan Adelaide, Inability to obtain consent, non-english speaking, Aborigines, palliative patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Patient Generated Subjective Global Assessment (PG-SGA) score.<br>[Baseline and at three months];European5 Quality of Life(EQ5D) Score[At baseline and then at three months];Hospital Re-admission rate<br>This will be determined by data linkage to patient medical records.[At three months as compared to control group]
- Secondary Outcome Measures
Name Time Method Cost-benefit analysis<br>The evaluation will be based on a primary outcome of cost per unit reduction in the PG-SGA( Patient generated Subjective Global Assessment) during the intervention period. That is, how much savings can be attributed to one unit of improvement in nutritional status. Utility-based outcomes will be incorporated into the analysis allowing a secondary outcome to be cost per QALY gained (based on the EQ5D level values). This will be determined using European Quality of Life Questionnaire(EQ5D) and Quality adjusted Life years(QALY) will be calculated.[At the end of three months as compared to control group.];Mortality[At three months as compared to control group.]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.